Section Arrow
Quote
RSLS.NASDAQ
- ReShape Lifesciences Inc.
Quotes are at least 15-min delayed:2025/06/29 20:13 EDT
Last
 2.44
+0.06 (+2.52%)
Day High 
2.59 
Prev. Close
2.38 
1-M High
8.29 
Volume 
445.24K 
Bid
2.42
Ask
2.43
Day Low
2.36 
Open
2.405 
1-M Low
2.23 
Market Cap 
5.68M 
Currency USD 
P/E 0.01 
%Yield -- 
10-SMA 2.63 
20-SMA 3.37 
50-SMA 5.99 
52-W High 414.99 
52-W Low 2.23 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
264.12/-16.50
Enterprise Value
5.72M
Balance Sheet
Book Value Per Share
0.52
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
11.24M
Operating Revenue Per Share
4.38
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed：2025/06/29 20:13 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.